Laika (EHR testing framework)

Global Attention Deficit Hyperactivity Disorder Market Report 2022: Increasing Recognition of Behavioral Therapy Benefits Boosts Sector - ResearchAndMarkets.com

Retrieved on: 
Friday, January 6, 2023
Pharmaceutical, Health, Neurology, Dextroamphetamine, Electronic health record, Amphetamine, Anxiety, Health, Central nervous system, Bipolar disorder, Clonidine, Depression, Brain, Parent, Narcolepsy, CNS, Johnson & Johnson, Growth, Patient, Attention deficit hyperactivity disorder, Speech, Attention, Movement, ADHD, Attention deficit hyperactivity disorder predominantly inattentive, Guanfacine, Antisocial personality disorder, Pharmacy, SNRI, Laika (EHR testing framework), Methylphenidate, Toy, Pharmaceutical industry

Based on drug type, the attention deficit hyperactivity disorder market is categorized into stimulants and non-stimulants.

Key Points: 
  • Based on drug type, the attention deficit hyperactivity disorder market is categorized into stimulants and non-stimulants.
  • The stimulants segment procured the highest revenue share in the attention deficit hyperactivity disorder market in 2021.
  • The retail pharmacy segment recorded the largest revenue share in the attention deficit hyperactivity disorder market in 2021.
  • On the basis of region, the attention deficit hyperactivity disorder market is analyzed across North America, Europe, Asia Pacific, and LAMEA.

Hospital-Acquired Infection Control Global Market Report 2022: Surging COVID-19 Cases Drives Demand and Fuels Growth - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 28, 2022
Infectious Diseases, Hospitals, Health, COVID-19, Benchmark, Philips, Agriculture, Infection, Subclinical infection, Hospital-acquired infection, Bloodstream infections, Coronavirus, COVID-19, Skin, Urinary tract infection, Health information management, Growth, Patient, Degenerative disease, Pneumonia, World Health Organization, Intensive care unit, Machine learning, Hospital, Create, Laika (EHR testing framework), Autoclave, First Nations in Ontario, Sterilization, United Nations, Nursing, Medical device, Animal, Marketing, Disinfectant

The "Hospital-Acquired Infection Control Global Market Report 2022: Ukraine-Russia War Impact" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Hospital-Acquired Infection Control Global Market Report 2022: Ukraine-Russia War Impact" report has been added to ResearchAndMarkets.com's offering.
  • The prevention and control of hospital-acquired infection using various cleaning, sterilization, and disinfection methods refers to hospital-acquired infection control.
  • The surge in COVID-19 cases is expected to propel the growth of the hospital-acquired infection control market going forward.
  • Major companies operating in the hospital-acquired infection control market are focused on developing new technological solutions to lead the market.

LiveCare Corp Launches "Clinii" AI-Enabled Real-Time Interpretations of Care Team Conversations to Improve Care, Clinician Productivity and Billing Accuracy

Retrieved on: 
Sunday, January 8, 2023
Communication, Innovation, Health, UC Davis Health Stadium, Workforce, Documentation, SAN, Digital, Patient, AI, Physician, JP, Cross-Strait CEO Summit, Digital health, Digital collaboration, UC, University of California, Davis, Nursing, Laika (EHR testing framework), CIO, MPH, Pharmaceutical industry, Medical device, Medicine, MD

SAN FRANCISCO, Jan. 8, 2023 /PRNewswire/ -- LiveCare Corp , a leading provider of virtual practice management tools for primary and specialty care providers, today announced the launch of an artificial intelligence-enabled functionality that interprets care team conversations in real time in order to uncover insights that improve patient care, billing accuracy and clinician experiences.

Key Points: 
  • SAN FRANCISCO, Jan. 8, 2023 /PRNewswire/ -- LiveCare Corp , a leading provider of virtual practice management tools for primary and specialty care providers, today announced the launch of an artificial intelligence-enabled functionality that interprets care team conversations in real time in order to uncover insights that improve patient care, billing accuracy and clinician experiences.
  • The functionality was announced at the UC Davis Health Future and CEO Summit during the JP Morgan 41st Healthcare Summit.
  • The AI-enabled tool is available as an embedded feature in LiveCare's platform and will allow health care organizations of all sizes to seamlessly harness these insights in order to automate documentation and improve the accuracy of billing.
  • "Some of the most critical insights about patient care are hidden in day-to-day workflows and conversations between patients, nurses, physicians and ancillary care providers.

Data Analytics Could Prevent Testing Bottlenecks During Future Pandemics

Retrieved on: 
Wednesday, January 4, 2023
Data science, COVID-19 testing, RSV, Journal, MD, Research, Infection, FACEP, COVID-19, EHR, MBA, Patient, Severe acute respiratory syndrome coronavirus 2, Sangal, PCR, St. Paul's Hospital, Linux, Laika (EHR testing framework), AACC, Workflow, Hospital, Pharmaceutical industry, Vaccine, Medical device

WASHINGTON, Jan. 4, 2023 /PRNewswire/ -- Breaking research demonstrates the efficacy of two data analytics-based strategies that clinical labs employed to meet COVID-19 testing demands during the height of the pandemic. These findings, published in the Data Science Issue of AACC's The Journal of Applied Laboratory Medicine, give labs a blueprint for using data analytics to ensure patient access to testing during future infectious disease outbreaks.

Key Points: 
  • These findings, published in the Data Science Issue of AACC's The Journal of Applied Laboratory Medicine, give labs a blueprint for using data analytics to ensure patient access to testing during future infectious disease outbreaks.
  • For symptomatic patients who were discharged from the emergency department, COVID-19 + flu/RSV testing decreased 49% while testing for COVID-19 + flu-only increased 160%.
  • These findings build on data analytics work from the start of the pandemic led by Daniel T. Holmes, MD, of St. Paul's Hospital in Vancouver, Canada, which demonstrated how labs can use data automation to handle outbreak-related testing surges.
  • From September – December 2020, this automated workflow decreased the lab's consumption of reagents for SARS-CoV-2 testing by approximately 58%.

Verana Health and Sight Sciences Collaborate on Glaucoma Research Using Curated Real-World Data from the IRIS Registry

Retrieved on: 
Wednesday, January 4, 2023
Exocrine gland, SAN, HCP, Optic nerve, Surgical instrument, Duane syndrome, Safety, Diabetic retinopathy, Health, Research, American Academy, Intraocular pressure, Patient, Trabecular meshwork, American Academy of Ophthalmology, American Academy of Neurology, PARK, IOP, Machine Intelligence Research Institute, Glaucoma, FDA, State, Geographic atrophy, Trauma, MD, Data management, American Urological Association, Severe cognitive impairment, Database, Doctor of Philosophy, RWD, MIGS, Quality of life, Surgeon, Catheter, HCPS, Laika (EHR testing framework), Medicine, Eye, IRIS, OMNI, MGD, Physician, Cataract, Pharmaceutical industry, Dentistry, Medical imaging, Medical device, Ophthalmology

SAN FRANCISCO and MENLO PARK Calif., Jan. 4, 2023 /PRNewswire/ -- Verana Health®—a digital health company elevating quality in real-world data (RWD)—and Sight Sciences, Inc. (NASDAQ: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients' lives, today announced a research collaboration designed to provide insights that may lead to improved outcomes for patients with primary open-angle glaucoma (POAG).

Key Points: 
  • Powered by real-world glaucoma data curated from the American Academy of Ophthalmology (Academy) IRIS® Registry (Intelligent Research in Sight), Qdata Glaucoma is the only data module that captures the full, real-world glaucoma patient journey.
  • This fit-for-purpose data module offers curated data for:
    The IRIS Registry is one of the largest specialty society clinical data registries in all of medicine and the first comprehensive eye disease clinical registry in the U.S.
  • Michael Mbagwu, MD, senior medical director for Verana Health says, "Sight Sciences shares our goal of improving outcomes and treatments for people with glaucoma.
  • Using its clinician-informed and artificial intelligence-enhanced VeraQ® population health data engine, Verana Health transforms structured and unstructured healthcare data into curated, disease-specific data modules, Qdata®.

Darena Solutions Launches MeldRx™ Hub: A Directory of Over 2000 FHIR API Endpoints of MeldRx™ Customers

Retrieved on: 
Wednesday, January 4, 2023
Annual Reviews (publisher), Patient, 21st Century Cures Act, Health, Directory, Laika (EHR testing framework), Luke, Patient Provider, ONC, Failure, Ecosystem, API, Darenan, CAP, Certification, FHIR, Medical device, Payment, Providers

ST. LOUIS, Jan. 4, 2023 /PRNewswire-PRWeb/ -- Darena Solutions announces the launch of MeldRx™ Hub, a centralized directory of FHIR Application Programming Interfaces (APIs) for healthcare organizations that are part of the MeldRx™ ecosystem. The Cures Act requires EHRs to publish FHIR API endpoints in a machine-readable and easily accessible format for free. By sharing these API endpoints publicly, EHRs can facilitate the exchange of healthcare data through third-party apps. MeldRx™ Hub helps EHRs and healthcare organizations meet this requirement and take advantage of the FHIR-based apps.

Key Points: 
  • The Cures Act requires EHRs to publish FHIR API endpoints in a machine-readable and easily accessible format for free.
  • By sharing these API endpoints publicly, EHRs can facilitate the exchange of healthcare data through third-party apps.
  • With streamlined processes, MeldRx™ can help EHRs address the (g)(10) FHIR API, the FHIR API activation, and the FHIR API Directory listing for all providers to achieve Cures Act compliance within days.
  • Darena Solutions delivers an Ecosystem of FHIR® enabled interoperability, regulatory compliance, and analytics solutions to EHRs, Providers, and Payers.

Klara® Named 2022 Winner of BIG Award for Business by the Business Intelligence Group

Retrieved on: 
Tuesday, December 20, 2022
Mobile, Wireless, Technology, Health Technology, Software, Practice Management, Other Health, Managed Care, General Health, Health, Data Management, Internal medicine, Business intelligence, Patient, Family, Gastroenterology, Communication, Elective surgery, Dermatology, RCM, Heart, Health information management, Blog, Pain management, Laika (EHR testing framework), OBGYN, Business, Allergy, Practice management, Multimedia, Pediatrics, Podiatry, EHR, Otorhinolaryngology, Medicine, Ophthalmology, Physician

Klara® , a leader in patient communication and engagement, announced today that it received the Business Intelligence Group’s BIG Award for Business and was named a 2022 Product of the Year.

Key Points: 
  • Klara® , a leader in patient communication and engagement, announced today that it received the Business Intelligence Group’s BIG Award for Business and was named a 2022 Product of the Year.
  • View the full release here: https://www.businesswire.com/news/home/20221220005055/en/
    Klara® Named 2022 Winner of BIG Award for Business by the Business Intelligence Group.
  • (Graphic: Business Wire)
    Klara is a conversational patient engagement platform at the forefront of revolutionizing the healthcare experience by streamlining patient communication, so every patient can receive excellent care.
  • The Business Intelligence Group was founded with the mission of recognizing true talent and superior performance in the business world.

Amalgam Rx™ Enhances Partnership with Novo Nordisk®

Retrieved on: 
Monday, December 19, 2022
Nanotechnology, Other Science, Pharmaceutical, Research, Software, Medical Devices, Hospitals, Data Management, Stem Cells, Science, Technology, Practice Management, Clinical Trials, General Health, Biotechnology, Diabetes, Health, Health Technology, Organization, Corporation, Patient, Digital, Anxiety, Self-management, Partnership, Health information management, HCPS, Hearing, Laika (EHR testing framework), Diabetes, Multimedia, Algorithm, Novo Nordisk, Software as a service, Insulin, Workflow, Pharmaceutical industry, Amalgam

The new agreement bolsters the existing partnership and product suite between Novo Nordisk and Amalgam by incorporating and integrating with connected insulin delivery devices, continuous glucose monitors, and electronic health records (EHRs).

Key Points: 
  • The new agreement bolsters the existing partnership and product suite between Novo Nordisk and Amalgam by incorporating and integrating with connected insulin delivery devices, continuous glucose monitors, and electronic health records (EHRs).
  • Novo Nordisk is also making an equity investment in Amalgam.
  • View the full release here: https://www.businesswire.com/news/home/20221219005188/en/
    Amalgam Rx™ Enhances Partnership with Novo Nordisk® (Graphic: Business Wire)
    Dose Check is a digital insulin initiation and titration app developed to help people with type 2 diabetes using basal insulin.
  • We are very proud of the program’s progress to date and of our collaboration with Novo Nordisk,” said Ryan Sysko, Chief Executive Officer, Amalgam Rx.

Clinical Genomics AI Commercial Use Cases Analyses Report 2022: Highlights of 14 Most Admired and Innovative Companies

Retrieved on: 
Thursday, December 29, 2022
DL, TEMPUS, Informatics, Siemens Healthineers, Whole genome sequencing, AI, RNA transfection, Diagnosis, Laika (EHR testing framework), Precision medicine, SWOT, Genomics, Sophia Genetics, Automation, DNAnexus, Therapy, Original equipment manufacturer, Algorithm, Deep learning, Research, Artificial intelligence, Machine learning, Hospital, University, Biomarker, Medical device, Antibiotics

DUBLIN, Dec. 29, 2022 /PRNewswire/ -- The "AI Commercial Use Cases, Impact Analyses, and Growth Opportunities in Clinical Genomics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Dec. 29, 2022 /PRNewswire/ -- The "AI Commercial Use Cases, Impact Analyses, and Growth Opportunities in Clinical Genomics" report has been added to ResearchAndMarkets.com's offering.
  • The study highlights fourteen 'Use Cases and Impact Analyses' of some of the most admired and innovative companies, such as Bionano Genomics, Inc, Deepcell, Inc., Fabric Genomics, Q-State Biosciences, Inc. TEMPUS, Sophia Genetics, Illumina, Qiagen, MolecularMatch, PierianDx, Inc., Dante Labs Inc., Microsoft Genomics, Intel Genomics, and Siemens Healthineers.
  • Clinical genomics regained significance during the pandemic with the development of the mRNA COVID-19 vaccine, and several non-invasive at-home test kits; an unprecedented feat in recent times.
  • Genomics will take center stage, as large genome sequencing and research will continuously create data for new therapeutics.

Sigmund Software Selects Darena Solutions' MeldRx™ to Meet Cures Act Requirements

Retrieved on: 
Wednesday, December 21, 2022
Patient, Addiction, 21st Century Cures Act, Win32 Thread Information Block, Environment, Partnership, Health Research Development Information Network, Electronic health record, Laika (EHR testing framework), Luke, Patient Provider, Ecosystem, EHR, Darenan, API, ST, Roger Hawkins (drummer), Mental health, FHIR, Record, Medical device, Payment, Providers

ST. LOUIS, Dec. 21, 2022 /PRNewswire-PRWeb/ -- MeldRx, a product owned by Darena Solutions, will enable providers using Sigmund's Electronic Health Record (EHR) to share records with patients easily. This partnership aligns with the 21st Century Cures Act provisions, which seek to improve the sharing of medical records between healthcare providers and patients in HL7®FHIR® format, thus preventing Information Blocking.

Key Points: 
  • Darena Solutions and Sigmund Software have announced a partnership to improve the sharing of medical records between healthcare providers and their patients and achieve (g)(10) FHIR API Cures Act compliance.
  • This partnership aligns with the 21st Century Cures Act provisions, which seek to improve the sharing of medical records between healthcare providers and patients in HL7®FHIR® format, thus preventing Information Blocking.
  • "Making it easy for healthcare providers to share data is instrumental for enabling patients' access to their data," said Pawan Jindal, CEO of Darena Solutions.
  • Sigmund Software develops, distributes, and supports Electronic Health Record (EHR) software for the Behavioral Health and Addiction Treatment community.